Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid
| Autor: | Vadhan-Raj, S. *, von Moos, R., Fallowfield, L.J., Patrick, D.L., Goldwasser, F., Cleeland, C.S., Henry, D.H., Novello, S., Hungria, V., Qian, Y., Feng, A., Yeh, H., Chung, K. |
|---|---|
| Zdroj: | In Annals of Oncology December 2012 23(12):3045-3051 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|